INTERVAL CANCERS IN THE SCREENING OF PROSTATE CANCER: RESULTS FROM THE HELSINKI AREA OF THE ERSPC STUDY

被引：0
|
作者：
Santti, H. [1 ]
Joutsi, T. [2 ]
Maattanen, L. [3 ]
Tammela, T. [4 ]
Ruutu, M. [1 ]
Auvinen, A. [5 ]
机构：
[1] Univ Helsinki, Ctr Hosp, Dept Urol, Helsinki, Finland
[2] Pori Cent Hosp, Dept Surg, Pori, Finland
[3] Finnish Canc Registry, FIN-00170 Helsinki, Finland
[4] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[5] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60950-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 305
页数：2
相关论文
共 50 条
  • [11] Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    Schroder, Fritz H.
    Hugosson, Jonas
    Roobol, Monique J.
    Tammela, Teuvo L. J.
    Zappa, Marco
    Nelen, Vera
    Kwiatkowski, Maciej
    Lujan, Marcos
    Maattanen, Liisa
    Lilja, Hans
    Denis, Louis J.
    Recker, Franz
    Paez, Alvaro
    Bangma, Chris H.
    Carlsson, Sigrid
    Puliti, Donella
    Villers, Arnauld
    Rebillard, Xavier
    Hakama, Matti
    Stenman, Ulf-Hakan
    Kujala, Paula
    Taari, Kimmo
    Aus, Gunnar
    Huber, Andreas
    van der Kwast, Theo H.
    van Schaik, Ron H. N.
    de Koning, Harry J.
    Moss, Sue M.
    Auvinen, Anssi
    LANCET, 2014, 384 (9959): : 2027 - 2035
  • [12] Screening for prostate cancer: Results about first screening round from the French population of the ERSPC trial
    Richard, F.
    PROGRES EN UROLOGIE, 2009, 19 (07): : 499 - 500
  • [13] Final results of the initial and second prostate cancer screening round of the European randomized study of screening for prostate cancer (ERSPC, section Rotterdam)
    Roobol, MJ
    De Vries, SH
    Schröder, FH
    JOURNAL OF UROLOGY, 2004, 171 (04): : 165 - 165
  • [14] Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
    Monique J. Roobol
    F. H. Schröder
    Jonas Hugosson
    J. Stephen Jones
    Michael W. Kattan
    Eric A. Klein
    Freddie Hamdy
    David Neal
    Jenny Donovan
    Dipen J. Parekh
    Donna Ankerst
    George Bartsch
    Helmut Klocker
    Wolfgang Horninger
    Amine Benchikh
    Gilles Salama
    Arnauld Villers
    Stephen J. Freedland
    Daniel M. Moreira
    Andrew J. Vickers
    Hans Lilja
    Ewout W. Steyerberg
    World Journal of Urology, 2012, 30 : 149 - 155
  • [15] Interval cancers in the Antwerp European randomised study of screening for prostate cancer study, using a 6 year screening interval
    Nelen, Vera
    Thys, Guy
    Hermans, Annemie
    D'Hooge, Kristien
    Dourcy-Belle-Rose, Brigitte
    Coebergh, Jan-Willem
    Roobol, Monique
    Denis, Louis
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3090 - 3094
  • [16] ERSPC Rotterdam: screening detects prostate cancers with favorable characteristics
    Nature Clinical Practice Urology, 2007, 4 (1): : 8 - 9
  • [17] Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
    Roobol, Monique J.
    Schroder, F. H.
    Hugosson, Jonas
    Jones, J. Stephen
    Kattan, Michael W.
    Klein, Eric A.
    Hamdy, Freddie
    Neal, David
    Donovan, Jenny
    Parekh, Dipen J.
    Ankerst, Donna
    Bartsch, George
    Klocker, Helmut
    Horninger, Wolfgang
    Benchikh, Amine
    Salama, Gilles
    Villers, Arnauld
    Freedland, Stephen J.
    Moreira, Daniel M.
    Vickers, Andrew J.
    Lilja, Hans
    Steyerberg, Ewout W.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 149 - 155
  • [18] Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up
    Bill-Axelson, Anna
    Bratt, Ola
    EUROPEAN UROLOGY, 2015, 67 (01) : 175 - 175
  • [19] Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up
    van Rij, Simon
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2014, 66 (06) : 1187 - 1188
  • [20] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Schroder, Fritz H.
    Hugosson, Jonas
    Carlsson, Sigrid
    Tammela, Teuvo
    Maattanen, Liisa
    Auvinen, Anssi
    Kwiatkowski, Maciej
    Recker, Franz
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2012, 62 (05) : 745 - 752
12345